In Vivo High Resolution Three-Dimensional Imaging of Antigen-Specific Cytotoxic T-Lymphocyte Trafficking to Tumors

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6838-6846

  Kircher, Moritz F ^a   Allport, Jennifer R ^a   Graves, Edward E ^c   Love, Victoria ^b   Josephson, Lee ^a   Lichtman, Andrew H ^b   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IRON OXIDE; NANOPARTICLE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ARTICLE; CELL LABELING; CELL TRANSPORT; CROSS LINKING; CYTOTOXIC T LYMPHOCYTE; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ANIMALS; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CROSS-LINKING REAGENTS; EPITOPES, T-LYMPHOCYTE; FEMALE; FERRIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NANOTECHNOLOGY; PARTICLE SIZE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0142188700     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Dove, A. Cell-based therapies go live. Nat. Biotechnol., 20: 339-343, 2002.
2. Valone, F. H., Small, E., MacKenzie, M., Burch, P., Lacy, M., Peshwa, M. V., and Laus, R. Dendritic cell-based treatment of cancer: closing in on a cellular therapy. Cancer J., 7: S53-61, 2001.
3. Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzenruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., Robinson, M. R., Raffield, M., Duray, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., Mavroukakis, S. A., White, D. E., and Rosenberg, S. A. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (Wash. DC), 298: 850-854, 2002.
4. Burt, R. K., and Traynor, A. Hematopoietic stem cell therapy of autoimmune diseases. Curr. Opin. Hematol., 5: 472-477, 1998.
5. Van Bekkum, D. W. Autologous stem cell therapy for treatment of autoimmune diseases. Exp. Hematol., 26: 831-834, 1998.
6. Semsarian, C. Stem cells in cardiovascular disease: from biology to clinical therapy. Int. Med. J., 32: 259-265, 2002.
7. Bessis, N., Cottard, V., Saidenburg-Kermanach, N., Lemeiter, D., Fournier, C., and Boissier, M. C. Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis. J. Gene Med., 4: 300-307, 2002.
8. Petit-Zeman, S. Regenerative medicine. Nat. Biotechnol., 19: 201-206, 2001.
9. Johnstone, B., and Yoo, J. Mesenchymal cell transfer for articular cartilage repair. Exp. Opin. Biol. Ther., 1: 915-921, 2001.
10. Billinghurst, L. L., Taylor, R. M., and Snyder, E. Y. Remyelination: cellular and gene therapy. Semin. Pediatr. Neurol., 5: 211-228, 1998.
11. Visonneau, S., Cesano, A., Torosian, M. H., and Santoli, D. Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice. Clin. Cancer Res., 3: 1491-1500, 1997.
12. Alvarez-Vallina, L. Genetic approaches for antigen selective therapy. Curr. Gene Ther., 1: 385-397, 2001.
13. Wen, Y. J., Min, R., Tricot, G., Barlogie, B., and Yi, Q. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Blood, 99: 3280-3285, 2002.
14. Soling, A., and Rainov, N. G. Dendritic cell therapy of primary brain tumors. Mol. Med., 7: 659-667, 2001.
15. Lesimple, T., Moisan, A., and Toujas, L. Autologous human macrophages and anti-tumor cell therapy. Res. Immunol., 149: 663-671, 1998.
16. Xu, Y. X., Gao, X., Janakiraman, N., Chapman, R. A., and Gautam, S. C. IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment. Clin. Immunol., 98: 180-189, 2001.
17. Paul, S., Calmels, B., and Acres, R. B. Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transfer. Curr. Gene Ther., 2: 91-100, 2002.
18. Tirapu, I., Rodriguez-Calvillo, M., Qian, C., Duarte, M., Smerdou, C., Palencia, B., Mazzolini, G., Prieto, J., and Melero, I. Cytokine gene transfer into dendritic cells for cancer treatment. Curr. Gene Ther., 2: 79-89, 2002.
19. May, K. F., Jr., Chen, L., Zheng, P., and Liu, Y. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells. Cancer Res., 62: 3459-3465, 2002.
20. Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., and Allen, P. M. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity, 13: 265-276, 2002.
21. Cardoso, A. A., Veiga, J. P., Ghia, P., Afonso, H. M., Haining, W. N., Sallan, S. E., and Nadler, L. M. Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies. Neoplasia, 94: 3531-3540, 1999.
22. Chapman, A. L., Rickinson, A. B., Thomas, W. A., Jarrett, R. F., Crocker, J., and Lee, S. P. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res., 61: 6219-6226, 2001.
23. Yang, S., Linette, G. P., Longerich, S., and Haluska, F. G. Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated with TCR avidity. J. Immunol., 169: 532-539, 2002.
24. Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., and Greenberg, P. D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. USA, 99: 16168-16173, 2002.
25. Stanislawski, T., Voss, R. H., Lotz, C., Sadovnikova, E., Willemsen, R. A., Kuball, J., Ruppert, T., Bolhuis, R. L., Melief, C. J., Huber, C., Stauss, H. J., and Theobald, M. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol., 2: 962-970, 2001.
26. Valmori, D., Pittet, M. J., Rimoldi, D., Lienard, D., Dunbar, R., Cerundolo, V., Lejeune, F., Cerottini, J. C., and Romero, P. An antigen-targeted approach to adoptive transfer therapy of cancer. Cancer Res., 59: 2167-2173, 1999.
27. Wang, R. F., and Rosenberg, S. A. Human tumor antigens for cancer vaccine development. Immunol. Rev., 170: 85-100, 1999.
28. Yee, C., Riddell, S. R., and Greenberg, P. D. In vivo tracking of tumor-specific T cells. Curr. Opin. Immunol., 13: 141-146, 2001.
29. Koike, C., Oku, N., Watanabe, M., Tsukada, H., Kakiuchi, T., Irimura, T., and Okada, S. Real-time PET analysis of metastatic tumor cell trafficking in vivo and its relation to adhesion properties. Biochim. Biophys. Acta, 1238: 99-106, 1995.
30. Adonai, N., Nguyen, K. N., Walsh, J., Iyer, M., Toyokuni, T., Phelps, M. E., McCarthy, T., McCarthy, D. W., and Gambhir, S. S. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl. Acad. Sci. USA, 99: 3030-3035, 2002.
31. Hardy, J., Edinger, M., Bachmann, M. H., Negrin, R. S., Fathman, C. G., and Contag, C. H. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol., 29: 1353-1360, 2001.
32. Jain, R. K., Munn, L. L., and Fukumura, D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer, 2: 266-276, 2000.
33. Tjuvajev, J. G., Doubrovin, M., Akhurst, T., Cai, S., Balatoni, J., Alauddin, M. M., Finn, R., Bornmann, W., Thaler, H., Conti, P. S., and Blasberg, R. G. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSVI-tk gene expression. J. Nucl. Med., 43: 1072-1083, 2002.
34. Bulte, J. W., Douglas, T., Witwer, B., Zhang, S. C., Strable, E., Lewis, B. K., Zywicke, H., Miller, B., van Gelderen, P., Moskowitz, B. M., Duncan, I. D., and Frank, I. A. Magnetodimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol., 19: 1141-1147, 2001.
35. Bulte, J. W. M., Zhang, S-C., van Gelderen, P., Herynek, V., Jordan, E. K., Duncan, I. D., and Frank, J. A. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA, 96: 15256-15261, 1999.
36. Dodd, C. H., Hsu, H., Chu, W., Yang, P., Zhang, H., Mountz, J. D., Zinn, K., Forder, J., Josephson, L., Weissleder, R., Mountz, J. M., and Mountz, J. D. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J. Immunol. Methods, 256: 89-105, 2001.
37. Lewin, M., Carlesso, N., Tung, C. H., Tang, X. W., Cory, D., Seadden, D. T., and Weissleder, R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol., 18: 410-414, 2000.
38. Zhao, M., Kircher, M. F., Josephson, L., and Weissleder, R. Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconj. Chem., 13: 840-844, 2002.
39. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., and Carbone, F. R. T cell receptor antagonist peptides induce positive selection. Cell, 76: 17-27, 1994.
40. Brown, D. M., Fisher, T. L., Wei, C., Frelinger, J. G., and Lord, E. M. Tumours can act as adjuvants for humoral immunity. Immunology, 102: 486-497, 2001.
41. Delfs, M. W., Furukawa, Y., Mitchell, R. N., and Liehtman, A. H. CD8+ T cell subsets TC1 and TC2 cause different histopathological forms of murine cardiac allograft rejection. Transplantation, 71: 606-610, 2001.
42. Allport, J. R., Lim, Y-C., Shipley, J. M., Senior, R. M., Shapiro, S. D., Matsuyoshi, N., Vestweber, D., and Luscinskas, F. W. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J. Leukoc. Biol., 71: 821-828, 2002.
43. Josephson, L., Tung, C., Moore, A., and Weissleder, R. High efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconj. Chem., 10: 186-191, 1999.
44. Beyer, K., Hausler, T., Kircher, M., Nickel, R., Wahn, U., and Renz, H. Specific V β T cell subsets are associated with cat and birch pollen allergy in humans. J. Immunol., 162: 1186-1191, 1999.
45. Wang, B., Norbury, C. C., Greenwood, R., Bennink, J. R., Yewdell, J. W., and Frelinger, J. A. Multiple paths for activation of naive CD8+ T cells: CD4-independent help. J. Immunol., 167: 1283-1289, 2001.
46. Lagasse, E., and Weissman, I. L. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods, 197: 139-150, 1996.
47. Moore, A., Sun, P. Z., Cory, D., Hogemann, D., Weissleder, R., and Lipes, M. A. MRI of insulitis in autoimmune diabetes. Magn. Reson. Med., 47: 751-758, 2002.
48. Ben-Hur, H., Kossoy, G., Zandbank, J., and Zusman, I. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors. Int. J. Mol. Med., 9: 425-430, 2002.
49. Perambakam, S., Naresh, K., Nerurkar, A., and Nadkarni, J. Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin's lymphoma. Pathol. Oncol. Res., 6: 114-117, 2000.
50. Lotze, M., Shurin, M., Davis, I., Amoscato, A., and Storkus, W. Dendritic cell based therapy of cancer. In: Ricciardi-Castagnoli (ed.), Dendritic Cells in Fundamental and Clinical Immunology, pp. 551-569. New York: Plenum Press, 1997.
51. Dobrzanski, M. J., Reome, J. B., and Dutton, R. W. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell populations in established pulmonary metastases. J. Immunol., 162: 6671-6680, 1999.
52. Sigal, R., Vogl, T., Casselman, J., Moulin, G., Veillon, F., Hermans, R., Dubrulle, F., Viala, J., Bosq, J., Mack, M., Depondt, M., Mattelaer, C., Petit, P., Champsaur, P., Riehm, S., Dadashitazehozi, Y., de Jaegere, T., Marchal, G., Chevalier, D., Lemaitre, L., Kubiak, C., Helmberger, R., and Halimi, P. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur. J. Radiol., 12: 1104-1113, 2002.